Srilakshmi Vemulakonda, MD
Critical Care (Intensivists) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 32
- 8 carriers
- Offices
- 4
Offices
4 locations · University Healthcare Alliance · Bass Medical Group
Looking this up.
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
32 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Vemulakonda’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
32 of 32 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A97779 · Current
Licensed to practise in California · since 2006 · expires 2028-08-31 · University of Pune, Armed Forces Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$122,216
Medicare paid this office $122,216 for 458 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 241 | $49,890 | $119 |
| Critical care, first 30-74 minutes | 102 | $35,037 | $185 |
| New patient visit (45+ min) | 141 | $20,907 | $148 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 64 | $8,759 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $726 | $61 |
See all 9 services
| Return visit (30+ min) | 241 | $49,890 | $119 |
| Critical care, first 30-74 minutes | 102 | $35,037 | $185 |
| New patient visit (45+ min) | 141 | $20,907 | $148 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 64 | $8,759 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $726 | $61 |
| Test for exercise-induced lung stress | 16 | $537 | $34 |
| Test to determine lung volumes using gas dilution or washout | 37 | $371 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 38 | $326 | $9 |
| Test to examine how well the lungs exchange gases | 37 | $274 | $7 |
Who their Medicare patients are
458 Original Medicare patients in 2024. Average age 78 · Women 60% · Also on Medicaid 18% · Health risk score 1.81. At or below the middle of the specialty; the typical critical care (intensivists) clinician is at 2.58.
Conditions among them: High blood pressure 75% · Coronary heart disease 45% · COPD 38% · Diabetes 37% · Heart failure 36% · Atrial fibrillation 35% · Chronic kidney disease 32% · Cancer 24% · Depression 22% · Stroke 20% · Dementia 18%.
The office billed $597,869, Medicare allowed $158,405 and paid $122,216; for 1,014 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 458 | 1,014 | 78 | 1.81 | $597,869 | $122,216 |
| 2023 | 305 | 876 | 78 | 1.99 | $458,299 | $93,372 |
| 2022 | 351 | 1,141 | 78 | 1.89 | $667,823 | $136,612 |
| 2021 | 390 | 1,274 | 78 | 1.88 | $614,120 | $161,622 |
| 2020 | 203 | 534 | 78 | 2.33 | $245,640 | $73,385 |
| 2019 | 401 | 1,467 | 78 | 2.52 | $602,759 | $186,092 |
| 2018 | 245 | 1,309 | 76 | 3.51 | $448,000 | $132,084 |
| 2017 | 232 | 1,176 | 77 | 2.81 | $486,054 | $113,675 |
| 2016 | 237 | 663 | 75 | 3.22 | $257,796 | $79,783 |
| 2015 | 118 | 454 | 75 | 3.69 | $104,465 | $53,040 |
| 2014 | 169 | 369 | 75 | 2.63 | $229,889 | $66,601 |
| 2013 | 258 | 706 | 73 | 2.73 | $449,735 | $125,303 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Critical care, first 30-74 minutes | 85 | $42,660 | $186 |
| Return visit (30+ min) | 118 | $19,983 | $116 |
| New patient visit (45+ min) | 62 | $9,600 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $9,218 | $107 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,500 | $156 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $1,577 | $99 |
| Test to determine lung volumes using gas dilution or washout | 75 | $854 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 75 | $731 | $10 |
| Test to examine how well the lungs exchange gases | 75 | $683 | $9 |
| Test for exercise-induced lung stress | 21 | $673 | $32 |
2022: 12 services
| Critical care, first 30-74 minutes | 122 | $75,931 | $193 |
| Return visit (30+ min) | 117 | $20,340 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 79 | $12,522 | $93 |
| New patient visit (45+ min) | 70 | $10,098 | $144 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,175 | $178 |
| Long return visit (40+ min) | 13 | $2,023 | $156 |
| Critical care, each additional 30 minutes | 16 | $1,744 | $97 |
| Telephone medical discussion with physician, 21-30 minutes | 19 | $1,708 | $81 |
| Test for exercise-induced lung stress | 20 | $605 | $30 |
| Test to determine lung volumes using gas dilution or washout | 60 | $600 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 60 | $514 | $9 |
| Test to examine how well the lungs exchange gases | 59 | $468 | $8 |
2021: 12 services
| Critical care, first 30-74 minutes | 167 | $92,394 | $193 |
| Return visit (30+ min) | 111 | $22,738 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $17,824 | $94 |
| New patient visit (45+ min) | 67 | $10,462 | $156 |
| Telephone medical discussion with physician, 21-30 minutes | 29 | $4,815 | $115 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,178 | $177 |
| Critical care, each additional 30 minutes | 18 | $1,882 | $99 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 66 | $642 | $10 |
| Test to examine how well the lungs exchange gases | 63 | $495 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 25 | $239 | $10 |
| Test to determine lung volumes using sensors | 19 | $212 | $11 |
| Test to examine how well the lungs exchange gases | 21 | $173 | $8 |
2020: 7 services
| Critical care, first 30-74 minutes | 82 | $45,897 | $194 |
| Return visit (30+ min) | 61 | $9,738 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $6,143 | $95 |
| New patient visit (45+ min) | 37 | $5,406 | $146 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,221 | $185 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 15 | $183 | $12 |
| Test to examine how well the lungs exchange gases | 15 | $127 | $8 |
2019: 8 services
| Critical care, first 30-74 minutes | 142 | $78,980 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 217 | $55,027 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 96 | $17,906 | $177 |
| Return visit (30+ min) | 65 | $11,776 | $96 |
| New patient visit (45+ min) | 50 | $7,601 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $6,056 | $65 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 11 | $824 | $75 |
| Test to measure expiratory airflow and volume | 11 | $84 | $8 |
2018: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 176 | $75,766 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 129 | $25,761 | $179 |
| Return visit (30+ min) | 53 | $12,977 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 76 | $9,099 | $65 |
| New patient visit (45+ min) | 28 | $4,064 | $145 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 12 | $1,297 | $108 |
2017: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 142 | $49,072 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 119 | $22,006 | $172 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 86 | $13,437 | $62 |
| Return visit (30+ min) | 47 | $9,316 | $93 |
| Critical care, first 30-74 minutes | 18 | $9,236 | $188 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 16 | $2,426 | $59 |
| New patient visit (45+ min) | 12 | $1,752 | $146 |
| Short return visit (20+ min) | 18 | $1,462 | $64 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 13 | $1,132 | $87 |
2016: 6 services
| Critical care, first 30-74 minutes | 93 | $25,170 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 73 | $22,494 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $11,717 | $180 |
| Return visit (30+ min) | 36 | $6,746 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $4,501 | $64 |
| New patient visit (45+ min) | 28 | $4,257 | $152 |
2015: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 62 | $21,546 | $93 |
| Critical care, first 30-74 minutes | 46 | $15,160 | $194 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $9,544 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $3,629 | $65 |
2014: 4 services
| Critical care, first 30-74 minutes | 160 | $60,188 | $195 |
| Critical care, each additional 30 minutes | 13 | $1,467 | $98 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 12 | $1,281 | $107 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 12 | $1,146 | $96 |
2013: 5 services
| Critical care, first 30-74 minutes | 249 | $118,043 | $188 |
| Critical care, each additional 30 minutes | 21 | $2,308 | $96 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 13 | $1,357 | $97 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,225 | $94 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 11 | $1,019 | $93 |
Drugs they prescribed that Part D paid
$1,112,919
Pharmacies billed $1,112,919 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,191) in 2024. At or below the middle of the specialty; the typical critical care (intensivists) clinician is at 0%.
917 generic and 1,274 brand-name prescriptions · $1,112,919 in drug cost · 75 antibiotic prescriptions to 59 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 601 | $513,693 | $855 |
| Ofev | 20 | $182,962 | $9,148 |
| Breo Ellipta | 296 | $151,549 | $512 |
| Pirfenidone | 20 | $105,462 | $5,273 |
| Anoro Ellipta | 88 | $56,917 | $647 |
See all 21 drugs
| Trelegy Ellipta | 601 | $513,693 | $855 |
| Ofev | 20 | $182,962 | $9,148 |
| Breo Ellipta | 296 | $151,549 | $512 |
| Pirfenidone | 20 | $105,462 | $5,273 |
| Anoro Ellipta | 88 | $56,917 | $647 |
| Bevespi Aerosphere | 21 | $9,083 | $433 |
| Eliquis | 15 | $8,866 | $591 |
| Wixela Inhub | 64 | $7,932 | $124 |
| Fluticasone-Vilanterol | 19 | $6,899 | $363 |
| Albuterol Sulfate Hfa | 222 | $5,097 | $23 |
| Fluticasone-Salmeterol | 13 | $2,726 | $210 |
| Montelukast | 180 | $1,764 | $10 |
| Ventolin Hfa | 27 | $1,420 | $53 |
| Pantoprazole | 117 | $1,030 | $9 |
| Fluticasone Propionate | 62 | $695 | $11 |
| Prednisone | 127 | $672 | $5 |
| Clarithromycin | 26 | $582 | $22 |
| Azithromycin | 38 | $291 | $8 |
| Azelastine | 18 | $239 | $13 |
| Amlodipine Besylate | 15 | $74 | $5 |
| Furosemide | 18 | $38 | $2 |
Year by year
| 2024 | 2,191 | 389 | 0% (0) | 58% | $1,112,919 |
| 2023 | 1,471 | 286 | 0% (0) | 59% | $1,023,950 |
| 2022 | 1,142 | 217 | 0% (0) | 55% | $867,468 |
| 2021 | 876 | 168 | None | 50% | $714,222 |
| 2020 | 634 | 116 | 0% (0) | 59% | $440,374 |
| 2019 | 378 | 81 | 0% (0) | 53% | $171,627 |
| 2018 | 359 | 64 | 0% (0) | 50% | $71,968 |
| 2017 | 376 | 67 | None | 48% | $149,452 |
| 2016 | 334 | 58 | None | 44% | $123,335 |
| 2015 | 316 | 56 | 9% (28) | 51% | $52,961 |
| 2014 | 34 | 12 | 0% (0) | 50% | $2,927 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Ofev | 33 | $422,488 | $12,803 |
| Trelegy Ellipta | 290 | $265,005 | $914 |
| Breo Ellipta | 234 | $129,772 | $555 |
| Anoro Ellipta | 59 | $37,362 | $633 |
| Advair Diskus | 28 | $19,482 | $696 |
| Spiriva Respimat | 16 | $18,769 | $1,173 |
| Symbicort | 17 | $12,122 | $713 |
| Incruse Ellipta | 11 | $7,493 | $681 |
| Eliquis | 12 | $7,255 | $605 |
| Wixela Inhub | 41 | $7,120 | $174 |
| Advair Hfa | 11 | $6,382 | $580 |
| Fluticasone-Salmeterol | 16 | $5,807 | $363 |
| Albuterol Sulfate Hfa | 160 | $5,037 | $31 |
| Ventolin Hfa | 33 | $2,312 | $70 |
| Montelukast | 95 | $1,367 | $14 |
| Fluticasone Propionate | 42 | $855 | $20 |
| Azithromycin | 36 | $734 | $20 |
| Prednisone | 101 | $695 | $7 |
| Pantoprazole | 65 | $557 | $9 |
| Mycophenolate Mofetil | 12 | $370 | $31 |
| Omeprazole | 13 | $42 | $3 |
| Furosemide | 14 | $39 | $3 |
2022: 17 drugs
| Ofev | 37 | $476,659 | $12,883 |
| Trelegy Ellipta | 159 | $132,943 | $836 |
| Breo Ellipta | 225 | $112,899 | $502 |
| Spiriva Respimat | 13 | $14,240 | $1,095 |
| Anoro Ellipta | 19 | $12,360 | $651 |
| Advair Diskus | 14 | $11,854 | $847 |
| Wixela Inhub | 35 | $10,191 | $291 |
| Symbicort | 11 | $9,362 | $851 |
| Albuterol Sulfate Hfa | 116 | $5,341 | $46 |
| Arnuity Ellipta | 14 | $3,591 | $257 |
| Montelukast | 103 | $2,938 | $29 |
| Ventolin Hfa | 17 | $1,225 | $72 |
| Azithromycin | 30 | $1,056 | $35 |
| Pantoprazole | 58 | $919 | $16 |
| Fluticasone Propionate | 38 | $706 | $19 |
| Prednisone | 68 | $607 | $9 |
| Furosemide | 20 | $43 | $2 |
2021: 17 drugs
| Ofev | 33 | $399,585 | $12,109 |
| Trelegy Ellipta | 98 | $75,421 | $770 |
| Breo Ellipta | 121 | $64,059 | $529 |
| Advair Diskus | 15 | $15,518 | $1,035 |
| Symbicort | 18 | $15,295 | $850 |
| Spiriva Respimat | 12 | $12,152 | $1,013 |
| Anoro Ellipta | 12 | $8,291 | $691 |
| Wixela Inhub | 28 | $7,761 | $277 |
| Albuterol Sulfate Hfa | 127 | $6,082 | $48 |
| Theo-24 | 11 | $2,652 | $241 |
| Montelukast | 123 | $2,051 | $17 |
| Ventolin Hfa | 13 | $763 | $59 |
| Fluticasone Propionate | 24 | $434 | $18 |
| Azithromycin | 16 | $389 | $24 |
| Pantoprazole | 39 | $350 | $9 |
| Prednisone | 66 | $343 | $5 |
| Furosemide | 18 | $37 | $2 |
2020: 15 drugs
| Ofev | 25 | $269,660 | $10,786 |
| Breo Ellipta | 132 | $61,654 | $467 |
| Trelegy Ellipta | 40 | $35,856 | $896 |
| Spiriva Respimat | 19 | $15,223 | $801 |
| Wixela Inhub | 19 | $8,149 | $429 |
| Symbicort | 14 | $7,861 | $561 |
| Ventolin Hfa | 28 | $2,301 | $82 |
| Theo-24 | 14 | $2,173 | $155 |
| Albuterol Sulfate Hfa | 49 | $2,135 | $44 |
| Montelukast | 105 | $1,575 | $15 |
| Proair Hfa | 13 | $1,475 | $113 |
| Azithromycin | 11 | $761 | $69 |
| Pantoprazole | 19 | $278 | $15 |
| Prednisone | 41 | $240 | $6 |
| Fluticasone Propionate | 11 | $178 | $16 |
2019: 9 drugs
| Breo Ellipta | 79 | $31,485 | $399 |
| Spiriva Respimat | 16 | $10,671 | $667 |
| Symbicort | 12 | $9,666 | $805 |
| Ventolin Hfa | 23 | $1,628 | $71 |
| Proair Hfa | 16 | $1,460 | $91 |
| Montelukast | 97 | $1,076 | $11 |
| Albuterol Sulfate Hfa | 13 | $659 | $51 |
| Prednisone | 25 | $140 | $6 |
| Pantoprazole | 12 | $83 | $7 |
2018: 10 drugs
| Breo Ellipta | 63 | $24,834 | $394 |
| Spiriva Respimat | 22 | $15,709 | $714 |
| Advair Diskus | 17 | $7,863 | $463 |
| Symbicort | 11 | $6,219 | $565 |
| Anoro Ellipta | 13 | $5,232 | $402 |
| Ventolin Hfa | 24 | $1,448 | $60 |
| Proair Hfa | 15 | $1,183 | $79 |
| Montelukast | 65 | $638 | $10 |
| Prednisone | 28 | $181 | $6 |
| Fluticasone Propionate | 12 | $180 | $15 |
2017: 10 drugs
| Breo Ellipta | 44 | $17,602 | $400 |
| Advair Diskus | 32 | $13,714 | $429 |
| Spiriva Respimat | 23 | $11,952 | $520 |
| Symbicort | 12 | $6,176 | $515 |
| Anoro Ellipta | 12 | $4,313 | $359 |
| Ventolin Hfa | 13 | $897 | $69 |
| Montelukast | 48 | $489 | $10 |
| Pantoprazole | 22 | $181 | $8 |
| Prednisone | 13 | $75 | $6 |
| Omeprazole | 12 | $48 | $4 |
2016: 9 drugs
| Advair Diskus | 39 | $15,443 | $396 |
| Spiriva Respimat | 14 | $4,496 | $321 |
| Anoro Ellipta | 11 | $3,543 | $322 |
| Symbicort | 11 | $3,213 | $292 |
| Montelukast | 56 | $773 | $14 |
| Prednisone | 25 | $240 | $10 |
| Pantoprazole | 19 | $153 | $8 |
| Fluticasone Propionate | 13 | $106 | $8 |
| Furosemide | 11 | $19 | $2 |
2015: 10 drugs
| Advair Diskus | 39 | $13,728 | $352 |
| Spiriva Respimat | 19 | $5,546 | $292 |
| Spiriva | 11 | $3,394 | $309 |
| Proair Hfa | 29 | $1,969 | $68 |
| Montelukast | 27 | $412 | $15 |
| Ethambutol | 11 | $411 | $37 |
| Pantoprazole | 24 | $198 | $8 |
| Azithromycin | 20 | $130 | $7 |
| Methadone | 11 | $120 | $11 |
| Prednisone | 12 | $92 | $8 |
Money from drug and device companies
$17 in 2025
| 2025 | 1 | 1 | None | $17 |
| 2024 | 1 | 1 | None | $90 |
| 2023 | 1 | 1 | None | $15 |
| 2021 | 1 | 1 | None | $18 |
| 2019 | 3 | 3 | None | $70 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Insmed | Brinsupri | $17 | 1 payment
|
See the published payment
| Insmed | Education · 2025-11-06 | Brinsupri | $17 |
See earlier years (2024, 2023, 2021, 2019)
2024: $90
| Edwards Lifesciences | Hemosphere | $90 | 1 payment
|
2023: $15
| Intuitive Surgical | Da Vinci Surgical System | $15 | 1 payment
|
2021: $18
| Electromed | Smartvest | $18 | 1 payment
|
2019: $70
| Boehringer Ingelheim Pharmaceuticals | Ofev | $30 | 1 payment
|
| GlaxoSmithKline | Nucala | $27 | 1 payment
|
| Gilead Sciences | None | $13 | 1 payment
|
Checkups this office reported
14 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 94.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 51%That's more than half. | 162 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 59%That's more than half. | 152 |
| Breast cancer screeningEligible women who got a mammogram | 29%That's less than half. | 111 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 10%That's few of the people this applied to. | 73 |
| Checked for fall riskOlder patients screened for fall risk | 14%That's few of the people this applied to. | 280 |
| Colon cancer screeningEligible adults who got a colon cancer test | 19%That's few of the people this applied to. | 215 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 8%That's few of the people this applied to. | 343 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 0%That's few of the people this applied to. | 30 |
See the other 6 measures
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 90%That's most of the people this applied to. Worse on this measure. | 30 |
| HIV screeningEligible patients who were screened for HIV | 12%That's few of the people this applied to. | 136 |
| Medications listed in the chartVisits where the current medication list was documented | 97%That's most of the people this applied to. | 608 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 100%That's most of the people this applied to. | 55 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 83%That's most of the people this applied to. | 126 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 44%That's less than half. | 401 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Did a security review of patient data
- Exchanges records both ways with other health systems
- Improved the patient portal
- Lets patients read their visit notes
- Reports cases to public health electronically
- Shows lab and imaging costs when ordering tests
- Uses standard treatment protocols
- Exempt from e-prescribing
- Exempt from immunization registry reporting
- Exempt from query of the prescription drug monitoring program (pdmp)
Professional record
- NPI
- 1659584019
- Licence
- CA A97779California A97779: Current · expires 2028-08-31
- Group
- University Healthcare Alliance · Bass Medical Group
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- 2520 Samaritan Dr Ste 104b, San Jose, CA, 95124
- NPI first listed
- 2007-05-08
- NPI last updated
- 2025-02-10
- NPI record certified
- 2025-02-10
This is when the NPI record was last certified, not a medical board exam.